《大行報告》高盛下調中國軟件國際(00354.HK)目標價至10.85元 評級「買入」
高盛發表研究報告指,看好中軟國際(00354.HK)產品組合升級和客戶群多樣化,預測2023至2025年盈利複合增長率可達到29%。同時預期在毛利率增長及營運支出比率改善的帶動下,可抵銷來自最大客戶華為的負面影響,至2025年經營溢利率預測由今年的4.8%升至8%,回到2019至2020年水平。
該行指出,雖然傳統IT服務毛利率或因華為的定價壓力和競爭而保持在較低水平,但預計產品組合升級和客戶群的多元化,將推動公司的毛利率和盈利增長,維持「買入」評級;目標價則下調14.6%至10.85元。(gc/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.